Showing 181-185 of 185 results for "".
- Take That SKs! DermBiont’s SM-020 Topical Gel Performs Well in Phase 2 Studyhttps://practicaldermatology.com/news/take-that-sks-dermbionts-sm-020-topical-gel-performs-well-in-phase-2-study/2461623/More than 80% of seborrheic keratosis (SK) lesions treated for 14 to 28 days with DermBiont’s SM-020 gel 1.0% had at least a one-point improvement in Physician’s lesion assessment (PLA) score at last visit, according to Phase 2 trial data presented at the
- ISDIN Teams Up with The Claire Marie Foundation And The Ulman Foundation For Skin Cancer Awareness Monthhttps://practicaldermatology.com/news/isdin-teams-up-with-the-claire-marie-foundation-and-the-ulman-foundation-for-skin-cancer-awareness-month-1/2460027/Spain-based skincare company ISDIN is partnering with the Claire Marie Foundation and the Ulman Foundation in honor of Skin Cancer Awareness Month. For every Eryfotona Actinica Ultralight Emulsion SPF 50+ sunscreen sold during the month of May,
- Emil Tanghetti, MDhttps://practicaldermatology.com/profiles/emil-tanghetti-md/7N5rqk/He attended U.C Davis where he excelled in his studies and received early admission to UCLA School of Medicine after only three years of undergraduate studies. Upon completing his medical studies and a 1-year pathology fellowship Dr. Tanghetti graduated first in his class and received the Dean Warr…
- Miriam Bettencourt, MD, FAADhttps://practicaldermatology.com/profiles/miriam-bettencourt-md-faad/LbxP4z/Miriam S. Bettencourt, MD, is a board-certified Fellow of the American Academy of Dermatology, a clinical professor of dermatology at the University of Nevada, and an adjunct professor at Touro University. She practices medical and cosmetic dermatology and Mohs surgery at Thomas Dermatology’s Hende…
- Emily Ruiz, MD, MPHhttps://practicaldermatology.com/profiles/emily-ruiz-md-mph/jmxPVM/My area of clinical expertise is cutaneous oncology for non-melanoma skin cancer. All of my clinical time is dedicated to this field, and my goal is to optimize surgical, non-surgical, and novel approaches to managing skin cancer. The High-Risk Skin Cancer Clinic at Dana-Farber Cancer Institute, wh…
- Previous
- Next